7-39081900-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001370959.1(POU6F2):​c.106-3960A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.236 in 152,126 control chromosomes in the GnomAD database, including 5,168 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 5168 hom., cov: 32)

Consequence

POU6F2
NM_001370959.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0690

Publications

6 publications found
Variant links:
Genes affected
POU6F2 (HGNC:21694): (POU class 6 homeobox 2) This gene encodes a member of the POU protein family characterized by the presence of a bipartite DNA binding domain, consisting of a POU-specific domain and a homeodomain, separated by a variable polylinker. The DNA binding domain may bind to DNA as monomers or as homo- and/or heterodimers, in a sequence-specific manner. The POU family members are transcriptional regulators, many of which are known to control cell type-specific differentiation pathways. This gene is a tumor suppressor involved in Wilms tumor (WT) predisposition. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
POU6F2 Gene-Disease associations (from GenCC):
  • Wilms tumor 5
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001370959.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001370959.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POU6F2
NM_001370959.1
MANE Select
c.106-3960A>T
intron
N/ANP_001357888.1A0A6E1XZL4
POU6F2
NM_007252.4
c.19-3960A>T
intron
N/ANP_009183.3P78424-1
POU6F2
NM_001166018.2
c.19-3960A>T
intron
N/ANP_001159490.1P78424-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POU6F2
ENST00000518318.7
TSL:1 MANE Select
c.106-3960A>T
intron
N/AENSP00000430514.3A0A6E1XZL4
POU6F2
ENST00000403058.6
TSL:5
c.19-3960A>T
intron
N/AENSP00000384004.1P78424-1
POU6F2
ENST00000451021.5
TSL:4
n.158-3960A>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.236
AC:
35815
AN:
152008
Hom.:
5168
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.136
Gnomad AMI
AF:
0.215
Gnomad AMR
AF:
0.288
Gnomad ASJ
AF:
0.200
Gnomad EAS
AF:
0.729
Gnomad SAS
AF:
0.269
Gnomad FIN
AF:
0.253
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.245
Gnomad OTH
AF:
0.218
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.236
AC:
35827
AN:
152126
Hom.:
5168
Cov.:
32
AF XY:
0.242
AC XY:
17998
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.136
AC:
5636
AN:
41516
American (AMR)
AF:
0.288
AC:
4404
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.200
AC:
694
AN:
3468
East Asian (EAS)
AF:
0.728
AC:
3754
AN:
5156
South Asian (SAS)
AF:
0.269
AC:
1300
AN:
4828
European-Finnish (FIN)
AF:
0.253
AC:
2683
AN:
10584
Middle Eastern (MID)
AF:
0.123
AC:
36
AN:
292
European-Non Finnish (NFE)
AF:
0.245
AC:
16662
AN:
67986
Other (OTH)
AF:
0.218
AC:
462
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1334
2668
4003
5337
6671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.232
Hom.:
542
Bravo
AF:
0.239
Asia WGS
AF:
0.439
AC:
1523
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
3.0
DANN
Benign
0.65
PhyloP100
0.069
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10464366;
hg19: chr7-39121500;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.